Literature DB >> 2851469

Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion.

B M Frier1, B M Fisher, C E Gray, G H Beastall.   

Abstract

Acute insulin-induced hypoglycaemia in humans provokes autonomic neural activation and counterregulatory hormonal secretion mediated in part via hypothalamic stimulation. Many patients with Type 1 (insulin-dependent) diabetes have acquired deficiencies of counterregulatory hormonal release following hypoglycaemia. To study the integrity of the hypothalamic-pituitary and the sympatho-adrenal systems, the responses of pituitary hormones, beta-endorphin, glucagon and adrenaline to acute insulin-induced hypoglycaemia (0.2 units/kg) were examined in 16 patients with Type 1 diabetes who did not have autonomic neuropathy. To examine the effect of duration of diabetes these patients were subdivided into two groups (Group 1: 8 patients less than 5 years duration; Group 2: 8 patients greater than 15 years duration) and were compared with 8 normal volunteers (Group 3). The severity and time of onset of hypoglycaemia were similar in all 3 groups, but mean blood glucose recovery was slower in the diabetic groups (p less than 0.01). The mean responses of glucagon, adrenaline, adrenocorticotrophic hormone, prolactin and beta-endorphin were similar in all 3 groups, but the mean responses of growth hormone were lower in both diabetic groups than in the normal group (p less than 0.05). The mean increments of glucagon and adrenaline in the diabetic groups were lower than the normal group, but these differences did not achieve significance; glucagon secretion was preserved in several diabetic patients irrespective of duration of disease. Various hormonal responses to hypoglycaemia were absent or diminished in individual diabetic patients, and multiple hormonal deficiencies could be implicated in delaying blood glucose recovery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851469     DOI: 10.1007/bf00271586

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Detection of microalbuminuria in diabetic patients using a simple latex agglutination test.

Authors:  R J Spooner; R J Weir; B M Frier
Journal:  Clin Chim Acta       Date:  1987-07-15       Impact factor: 3.786

2.  Growth hormone and glucose interrelationships in diabetes: studies of inadvertent hypoglycemic episodes during continuous blood glucose analysis.

Authors:  G D Molnar; V Fatourechi; E Ackerman; W F Taylor; J W Rosevear; L C Gatewood; F J Service; K E Moxness
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

Review 3.  Testing for autonomic neuropathy.

Authors:  J Hilsted
Journal:  Ann Clin Res       Date:  1984

4.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

5.  Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy.

Authors:  F P Kennedy; V L Go; P E Cryer; G B Bolli; J E Gerich
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

6.  Diabetes induced by streptozocin results in a decrease in immunoreactive beta-endorphin levels in the pituitary and hypothalamus of female rats.

Authors:  L J Forman; D E Marquis; R Stevens; R Adler; P Vasilenko
Journal:  Diabetes       Date:  1985-11       Impact factor: 9.461

7.  Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics.

Authors:  T Krarup; T W Schwartz; J Hilsted; S Madsbad; O Verlaege; L Sestoft
Journal:  Br Med J       Date:  1979-12-15

8.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

Authors:  N H White; D A Skor; P E Cryer; L A Levandoski; D M Bier; J V Santiago
Journal:  N Engl J Med       Date:  1983-03-03       Impact factor: 91.245

9.  Rapid radioimmunoassay for corticotropin in unextracted human plasma.

Authors:  W E Nicholson; D R Davis; B J Sherrell; D N Orth
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

10.  The importance of plasma free insulin and counterregulatory hormones for the recovery of blood glucose following hypoglycaemia in type 1 diabetics.

Authors:  S Madsbad; J Hilsted; T Krarup; L Sestoft; N J Christensen; B Tronier
Journal:  Acta Endocrinol (Copenh)       Date:  1985-02
View more
  7 in total

1.  Unawareness of hypoglycaemia.

Authors: 
Journal:  BMJ       Date:  1990-11-10

2.  Monitoring set-up for selection of parameters for detection of hypoglycaemia in diabetic patients.

Authors:  G Heger; K Howorka; H Thoma; G Tribl; J Zeitlhofer
Journal:  Med Biol Eng Comput       Date:  1996-01       Impact factor: 2.602

3.  Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects.

Authors:  H Vea; R Jorde; G Sager; S Vaaler; J Sundsfjord
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

4.  The effect of a ventral medial hypothalamic lesion on the insulin-induced hypotensive response in normal rats.

Authors:  J Wright-Richey; S Schultz-Klarr; J C Dunbar
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

5.  Increase in plasma beta endorphins precedes vasodepressor syncope.

Authors:  D R Wallbridge; H E MacIntyre; C E Gray; M A Denvir; K G Oldroyd; A P Rae; S M Cobbe
Journal:  Br Heart J       Date:  1994-05

6.  Hypothalamic-pituitary activation does not differ during human and porcine insulin-induced hypoglycemia in insulin-dependent diabetes mellitus.

Authors:  T Lingenfelser; A Pickert; M Pfohl; W Renn; M Radjaipour; C Collet; M Eggstein; B Jakober
Journal:  Clin Investig       Date:  1993-12

7.  Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.

Authors:  Jessica T Y Yue; Elena Burdett; David H Coy; Adria Giacca; Suad Efendic; Mladen Vranic
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.